Tilray Brands (TLRY) Cash & Current Investments (2017 - 2026)
Tilray Brands (TLRY) reported Cash & Current Investments of $60.2 million for Q1 2026, down 79.35% quarter-over-quarter from $291.6 million in Q4 2025.
Tilray Brands (TLRY) Cash & Current Investments (2017 - 2026) Analysis & Trends
Tilray Brands has reported Cash & Current Investments for 10 years, with the latest figure at $60.2 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments changed N/A year-over-year to $60.2 million; the trailing twelve-month figure through Feb 2026 stood at $60.2 million (changed N/A YoY), and the FY2025 full-year result was $34.7 million, down 86.68% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $60.2 million, down from $291.6 million in the prior quarter.
- The five-year high for Cash & Current Investments was $490.6 million in Q3 2022, with the low at $34.7 million in Q2 2025.
- Historically, Cash & Current Investments has averaged $271.4 million across 5 years, with a median of $262.7 million in 2024.
- Annual changes were most pronounced in 2024 — Cash & Current Investments soared 56.34% — and 2025, when it plunged 86.68%.
- Tilray Brands' Cash & Current Investments stood at $433.5 million in 2022, then slumped by 40.07% to $259.8 million in 2023, then decreased by 2.9% to $252.2 million in 2024, then advanced by 15.58% to $291.6 million in 2025, then plunged by 79.35% to $60.2 million in 2026.
- The last three Cash & Current Investments figures came in at $60.2 million (Q1 2026), $291.6 million (Q4 2025), and $264.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 498.58 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 750.88 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 60.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 60.20 Mn |
| Nov 30, 2025 | 291.55 Mn |
| Aug 31, 2025 | 264.83 Mn |
| May 31, 2025 | 34.70 Mn |
| Nov 30, 2024 | 252.25 Mn |
| Aug 31, 2024 | 280.06 Mn |
| May 31, 2024 | 260.52 Mn |
| Feb 29, 2024 | 225.86 Mn |
| Nov 30, 2023 | 259.79 Mn |
| Aug 31, 2023 | 179.13 Mn |
| May 31, 2023 | 206.63 Mn |
| Feb 28, 2023 | 408.28 Mn |
| Nov 30, 2022 | 433.50 Mn |
| Aug 31, 2022 | 490.64 Mn |
| May 31, 2022 | 415.91 Mn |
| Feb 28, 2022 | 279.21 Mn |
| Nov 30, 2021 | 331.78 Mn |
| Aug 31, 2021 | 376.30 Mn |
| May 31, 2021 | 488.47 Mn |
| May 31, 2020 | 360.65 Mn |